Fat loss and metabolic health
Semaglutide
The GLP-1 that made appetite optional.
Semaglutide has strong human evidence for weight loss and glycemic control. The real question is not whether it works. It is whether users preserve muscle, hormones, and sanity while using it.
Mechanism
What it probably does
Semaglutide activates GLP-1 receptors, increasing satiety, slowing gastric emptying, improving glucose control, and reducing food intake.
Claims vs data
Where people get carried away
The evidence for weight loss is strong. The weak point is sloppy use: under-eating protein, skipping resistance training, and losing lean mass with the fat.
Why people use it
- •fat loss
- •appetite control
- •insulin resistance
- •type 2 diabetes
- •cardiometabolic risk
What to track
- •weight
- •waist
- •lean mass
- •protein intake
- •fasting glucose
- •HbA1c
- •lipids
- •testosterone
- •libido
In Short
Semaglutide works. That is the boring part now.
If the scale drops and strength craters, you bought weight loss with muscle.
Scientific evidence
Receipts before stories.
Anecdotal evidence
Not proof. Still useful signal.
Kabal angle
If you experiment, make the data impossible to ignore.
Kabal is built for the part most peptide pages skip: tracking the outcome, the dose, the timing, and the biomarkers that tell you whether the story holds up.
Get Kabal for iOS